ACNE VULGARIS
Clinical trials for ACNE VULGARIS explained in plain language.
Never miss a new study
Get alerted when new ACNE VULGARIS trials appear
Sign up with your email to follow new studies for ACNE VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Acne gel showdown: which works better?
Disease control Not yet recruitingThis study compares two prescription gels (metronidazole and clindamycin) for treating moderate acne in adults aged 18-35. Sixty participants will apply the assigned gel twice daily for 12 weeks. The goal is to see which gel reduces acne more effectively and safely.
Matched conditions: ACNE VULGARIS
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New acne gel shows promise in Head-to-Head face study
Symptom relief Not yet recruitingThis study tests a new topical gel containing spironolactone against a standard acne treatment (adapalene) in 40 people with mild to moderate acne. Each participant will apply the spironolactone gel to one side of their face and the adapalene gel to the other side, allowing a dir…
Matched conditions: ACNE VULGARIS
Phase: PHASE2 • Sponsor: Assiut University • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
New acne cream shows promise in clinical trial
Symptom relief Not yet recruitingThis study tests a new cream called KR230109 for mild to moderate facial acne in 180 adults aged 18 to 40. The goal is to see if the cream safely reduces pimples and skin bumps compared to a placebo over 12 weeks. Participants will apply the cream and have their skin checked at s…
Matched conditions: ACNE VULGARIS
Phase: PHASE2 • Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC
-
New acne gel studied in younger kids for first time
Symptom relief Not yet recruitingThis study tests a prescription gel called CABTREO in children aged 9 to 11 with moderate to severe acne. The gel combines three active ingredients to treat pimples and blackheads. Researchers will check how safe the gel is and how well it works over 12 weeks. About 100 kids will…
Matched conditions: ACNE VULGARIS
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC
-
New acne cream shows promise in large trial
Symptom relief Not yet recruitingThis study tests a cream called clascoterone for moderate to severe acne. About 692 people aged 12 and older will apply the cream or a placebo to their face twice daily for 12 weeks. The goal is to see if the cream safely reduces acne better than a placebo.
Matched conditions: ACNE VULGARIS
Phase: PHASE3 • Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC